sun pharmaceutical industries said thursday us food drug administrations usfda decision ban import products karkhadi plant gujarat hurt company much financially
facility dedicated cephalosporin plant usfda move little financial impact company sun pharma spokeswoman told business today elaborate
analysts say company source cephalosporin antibiotic considered lowvalue active pharmaceutical ingredient api facilities vendors escape financial hit
earlier thursday company said statement usfda move followed inspection facility identified noncompliance good manufacturing practices regulations drugmaker added initiated several corrective steps address observations made us regulator
analysts also say development could perception hit company given first ban indian facility analyst says even development leads two three per cent impact sales would hurt companys image
shares sun pharmaceutical recovered tad afternoon trade falling six per cent morning shares four per cent rs 58040 bombay stock exchange
